Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sudha Rao currently holds 250,000 shares of KAZIA THERAPEUTICS LTD (KZIA), valued at approximately $0. This represents their equity stake as Chief Scientific Officer.
Based on SEC Form 4 filings, Sudha Rao has been a net neutral trader of KZIA stock. They have purchased $0 and sold $0 worth of shares.
Sudha Rao's most recent insider trade was on Jun 19, 2026, when they sold 250,000 shares at $0.00 per share.
Sudha Rao serves as Chief Scientific Officer at KAZIA THERAPEUTICS LTD (KZIA). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Sudha Rao holds the position of Chief Scientific Officer at KAZIA THERAPEUTICS LTD, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Sudha Rao has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sudha Rao was on Jun 19, 2026, when they purchased $0 worth of KZIA shares. This transaction involved 250,000 shares at N/A per share.
Sudha Rao currently owns 250,000 shares of KAZIA THERAPEUTICS LTD (KZIA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sudha Rao's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sudha Rao has 1 Form 4 filings on record as an insider at KAZIA THERAPEUTICS LTD.
Set alerts for Sudha Rao and 40,000+ other insiders.